Jenna E. Rossoff, MD

Clinical and Community Trials
Contact: jrossoff@luriechildrens.org

“My focus is improving outcomes pediatric patients with high-risk hematologic malignancies and improve our management of infectious complications of cancer treatment in children.”

Research Interests

  • Pediatric Oncology
  • Leukemia
  • Infectious Complications of Cancer Therapy

Biography

  • Attending Physician, Hematology, Oncology, and Stem Cell Transplantation, Ann & Robert H. Lurie Children’s Hospital of Chicago 
  • Assistant Professor of Pediatrics (Hematology, Oncology, and Stem Cell Transplantation), Northwestern University Feinberg School of Medicine 

See Lurie Children's Provider Profile

Jenna Rossoff, MD, received her medical degree from Rutgers Robert Wood Johnson Medical School in 2013. She then went on to Ann & Robert H. Lurie Children’s Hospital of Chicago and the McGaw Medical Center of Northwestern University to complete her residency in Pediatrics in 2016 and fellowship in Pediatric Hematology, Oncology, and Stem Cell Transplant in 2019. After graduation, she joined the Pediatric Hematology, Oncology, and Stem Cell Transplant Division as a faculty member with a specialization in hematologic malignancies. Dr. Rossoff’s clinical focus centers on the treatment of pediatric and young adult patients with hematologic malignancies, including leukemia, lymphoma, hemophagocytic lymphohistiocytosis, and post-transplant lymphoproliferative disease. She also specializes in the treatment of pediatric patients with Castleman disease. 

Dr. Rossoff’s research interests are in the clinical investigation of high-risk leukemias and infectious complications of cancer therapy. Her primary areas of interest in high-risk leukemias are in the myeloid diseases and use of novel immunotherapy agents. She is a member of the Children’s Oncology Group Myeloid Disease Committee and is the institutional RI for its Cancer Control–Supportive Care Committee. Dr. Rossoff also actively participates in the Pediatric Real World CAR Consortium, which seeks to describe the collective clinical experience using CAR T cells as an FDA-approved therapy across more than 30 U.S. institutions. 

Education and Background

  • Fellowship in Hematology, Oncology, Neuro-Oncology, and Stem Cell Transplant, Ann & Robert H. Lurie Children’s Hospital of Chicago 2016-2019
  • Residency in Pediatrics, Northwestern University McGaw Medical Center 2013-2016
  • MD, Rutgers Robert Wood Johnson Medical School 2013

Similar Researchers

Clinical and Community Trials

Research Interests

Critical Care, Viral Respiratory Infections, Lung Injury and Repair, Immune Regulation

Recent Publication

Age-related Differences in the Nasal Mucosal Immune Response to SARS-CoV-2.

Clinical and Community Trials

Research Interests

Interventricular Mechanics, Right Ventricular Failure, Role of Immunologic Phenotype on Post-heart Transplant Outcomes, Post-heart Transplant Kidney Injury and Failure

Clinical and Community Trials